IL132391A0 - Preventives or remedies for diseases effecting excessive proliferation or retinal pigment eptihelial cells - Google Patents

Preventives or remedies for diseases effecting excessive proliferation or retinal pigment eptihelial cells

Info

Publication number
IL132391A0
IL132391A0 IL13239198A IL13239198A IL132391A0 IL 132391 A0 IL132391 A0 IL 132391A0 IL 13239198 A IL13239198 A IL 13239198A IL 13239198 A IL13239198 A IL 13239198A IL 132391 A0 IL132391 A0 IL 132391A0
Authority
IL
Israel
Prior art keywords
preventives
remedies
retinal pigment
excessive proliferation
eptihelial
Prior art date
Application number
IL13239198A
Other languages
English (en)
Original Assignee
Kissei Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kissei Pharmaceutical filed Critical Kissei Pharmaceutical
Publication of IL132391A0 publication Critical patent/IL132391A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
IL13239198A 1997-04-18 1998-04-10 Preventives or remedies for diseases effecting excessive proliferation or retinal pigment eptihelial cells IL132391A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP13567597 1997-04-18
PCT/JP1998/001654 WO1998047504A1 (fr) 1997-04-18 1998-04-10 Remedes pour la prophylaxie ou le traitement de maladies se traduisant par une proliferation excessive des cellules epitheliales pigmentaires de la retine

Publications (1)

Publication Number Publication Date
IL132391A0 true IL132391A0 (en) 2001-03-19

Family

ID=15157309

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13239198A IL132391A0 (en) 1997-04-18 1998-04-10 Preventives or remedies for diseases effecting excessive proliferation or retinal pigment eptihelial cells

Country Status (10)

Country Link
US (1) US6303655B1 (xx)
EP (1) EP1008347A4 (xx)
KR (1) KR20010006485A (xx)
CN (1) CN1252718A (xx)
AU (1) AU6748398A (xx)
CA (1) CA2286120A1 (xx)
IL (1) IL132391A0 (xx)
NZ (1) NZ500300A (xx)
RU (1) RU2207852C2 (xx)
WO (1) WO1998047504A1 (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002363075A (ja) * 2001-06-05 2002-12-18 Kao Corp 高血圧症予防・治療剤
US20050106230A1 (en) * 2003-11-17 2005-05-19 Young Janel E. Drug-enhanced adhesion prevention
AU2012200202B2 (en) * 2004-03-10 2013-09-05 Ethicon, Inc. Drug-enhanced adhesion prevention
WO2006073126A1 (ja) * 2005-01-06 2006-07-13 Kissei Pharmaceutical Co., Ltd. 慢性移植片対宿主症におけるドライアイの予防および治療剤
WO2008094992A2 (en) 2007-01-31 2008-08-07 Vertex Pharmaceuticals Incorporated 2-aminopyridine derivatives useful as kinase inhibitors
US8569337B2 (en) 2008-07-23 2013-10-29 Vertex Pharmaceuticals Incorporated Tri-cyclic pyrazolopyridine kinase inhibitors
CA2731451A1 (en) 2008-07-23 2010-01-28 Vertex Pharmaceuticals Incorporated Pyrazolopyridine kinase inhibitors
JP5631310B2 (ja) 2008-07-23 2014-11-26 バーテックス ファーマシューティカルズ インコーポレイテッドＶｅｒｔｅｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃｏｒｐｏｒａｔｅｄ 三環式ピラゾロピリジンキナーゼ阻害剤
MX2011001319A (es) * 2008-08-06 2011-04-05 Vertex Pharma Inhibidores de aminopiridina cinasa.
EP2200412A1 (en) * 2008-12-17 2010-06-23 Nederlandse Organisatie voor toegepast-natuurwetenschappelijk Onderzoek TNO Flexible electronic product and method for manufacturing the same
CN102459259A (zh) 2009-05-06 2012-05-16 沃泰克斯药物股份有限公司 吡唑并吡啶类
EP2582702A1 (en) 2010-01-27 2013-04-24 Vertex Pharmaceuticals Incorporated Pyrazolopyrimidine kinase inhibitors
CN102869663A (zh) 2010-01-27 2013-01-09 沃泰克斯药物股份有限公司 吡唑并吡嗪激酶抑制剂
CA2787315A1 (en) 2010-01-27 2011-08-04 Vertex Pharmaceuticals Incorporated Pyrazolopyridine kinase inhibitors
KR20230024331A (ko) * 2020-06-05 2023-02-20 오쿠렉스 피티와이 리미티드 눈 장애의 치료를 위한 화합물 및 방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07116029B2 (ja) * 1989-04-04 1995-12-13 キッセイ薬品工業株式会社 トラニラスト水溶液製剤
JP2617407B2 (ja) * 1992-09-14 1997-06-04 キッセイ薬品工業株式会社 血管内膜細胞過剰増殖疾患の予防および治療剤
KR19990082523A (ko) * 1996-02-15 1999-11-25 간자와 무츠와 혈관생성 억제제
JPH09278653A (ja) * 1996-04-05 1997-10-28 Santen Pharmaceut Co Ltd 網膜疾患治療剤
ATE235900T1 (de) * 1996-09-28 2003-04-15 Kissei Pharmaceutical Hemmer der subepithelialen turbidität
CA2267320A1 (en) * 1996-10-14 1998-04-23 Hiroshi Miyata Secondary cataract inhibitor
US6114383A (en) * 1997-02-14 2000-09-05 Kissei Pharmaceutical Co., Ltd. Drugs inhibiting progress of pterygium and postoperative recurrence of the same

Also Published As

Publication number Publication date
KR20010006485A (ko) 2001-01-26
CN1252718A (zh) 2000-05-10
EP1008347A1 (en) 2000-06-14
US6303655B1 (en) 2001-10-16
CA2286120A1 (en) 1998-10-29
AU6748398A (en) 1998-11-13
RU2207852C2 (ru) 2003-07-10
NZ500300A (en) 2001-01-26
EP1008347A4 (en) 2002-02-06
WO1998047504A1 (fr) 1998-10-29

Similar Documents

Publication Publication Date Title
EP0789592A4 (en) GENE EYE THERAPY
AU4886297A (en) Artificial cornea
AU4406896A (en) Facial tissue carpack
AU6396598A (en) Arylsulphonamides and analogues and their use for the treatment and neurovegetative disorders
AU2146299A (en) Artificial cornea
AU698509B2 (en) Compositions for the treatment of rheumatoid-based arthritic diseases
AU7582398A (en) Composition for treating skin conditions
IL132391A0 (en) Preventives or remedies for diseases effecting excessive proliferation or retinal pigment eptihelial cells
EP1007028A4 (en) TREATING GLAUCOMA WITH 8 ISO PROSTAGLANDINE
AU7772598A (en) Safety clothing for protecting the human body
AU2639299A (en) Remedies/preventives for parkinson's disease
IL129144A0 (en) Use of 1-hydroxy-2-pyridones for the treatment of skin diseases
PL336579A1 (en) Treatment of diseases associated with cytokinins
AU2068295A (en) Skin treatment composition
AU1541499A (en) Human phosphatases
AU5918598A (en) Human extracellular matrix-1
AU3144195A (en) Human brain specific kinase
AU9500798A (en) Human prl-1 phosphatase
AU5494298A (en) Pharmaceutical compositions for the treatment of the eye
AU2754997A (en) The treatment of plant diseases
AU1645599A (en) Human matrilin-3
AU8155898A (en) Human preprotachykinin b
AU6288698A (en) Apparatus for stimulating the human body
EP0774260A4 (en) REMEDY FOR CORNEAL AFFECTIONS
AU1289695A (en) Human stanniocalcin-alpha